PEARA provides high-impact regulatory intelligence and submission strategy designed to optimize approval success across SFDA and global markets.
From product registration to AI-powered consulting, we deliver end-to-end regulatory intelligence for pharmaceutical companies worldwide.
End-to-end regulatory strategy design for SFDA, GCC, and global markets. We navigate complex approval pathways so you don't have to.
Module 3 gap analysis, comparability assessments, and stability strategy to ensure your dossier meets the highest standards.
Drugs, biologics, medical devices, and IVDs — we handle the full spectrum of product registration across regulatory authorities.
Leverage artificial intelligence in regulatory workflows, from submission automation to intelligent document review.
Regulatory affairs, GMP compliance, and AI training programs designed for pharmaceutical professionals.
Comprehensive regulatory due diligence for mergers, acquisitions, and strategic partnerships in the pharmaceutical sector.
PEARA operates at the intersection of regulatory science, strategic consulting, and artificial intelligence. We don't simply support submissions — we architect approval strategies that optimize success across SFDA and global markets.
We combine deep regulatory expertise with cutting-edge AI capabilities to deliver outcomes that traditional consultancies cannot match. Our enterprise-ready framework ensures consistency, transparency, and measurable results.
Get a customized quotation for your regulatory project. Our team of experts is ready to design a strategy tailored to your needs.